within Pharmacolibrary.Drugs.ATC.J;

model J01DD14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.75,
    Cl             = 0.018333333333333333,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.00020999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 19.98
  );

  annotation(Documentation(
    info ="<html><body><p>Ceftibuten is a third-generation oral cephalosporin antibiotic used primarily for the treatment of infections caused by susceptible strains of bacteria, such as acute bacterial exacerbations of chronic bronchitis, pharyngitis, tonsillitis, and urinary tract infections. It is currently approved for use in several countries and is valued for its once-daily dosing and oral administration route.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral dose administration.</p><h4>References</h4><ol><li>G L Kearns, R A Young,Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.,Clinical pharmacokinetics,1994<a href='https://pubmed.ncbi.nlm.nih.gov/8194281/'>https://pubmed.ncbi.nlm.nih.gov/8194281/</a></li><li>W H Barr, M Affrime, C C Lin, V Batra,Pharmacokinetics of ceftibuten in children.,The Pediatric infectious disease journal,1995<a href='https://pubmed.ncbi.nlm.nih.gov/7567317/'>https://pubmed.ncbi.nlm.nih.gov/7567317/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DD14;
